{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:40:18Z","timestamp":1792456818390,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Accumulating evidence has shown that the dysfunction of mitochondria, the multifunctional organelles in various cellular processes, is a pivotal event in the development of various diseases, including human cancers. The molecular alterations in tumors that promote metabolic diversity and distinct targetable dependencies remain poorly defined. The mitochondrial transporter SLC25A20, also known as carnitine-acylcarnitine translocase (CACT), is crucial for fatty acid \u03b2-oxidation (FAO) by importing acylcarnitines into the mitochondrial matrix. Here, we demonstrate that SLC25A20 is significantly upregulated in lung adenocarcinoma (LUAD) tissues and cells, and its expression correlates with poor patient survival. Gain- and loss-of-function experiments reveal that SLC25A20 promotes tumor cell proliferation, survival, migration, and invasion by enhancing FAO-associated mitochondrial bioenergetics and suppressing apoptosis. Mechanistically, SLC25A20-mediated FAO maintains mitochondrial function and supports oxidative phosphorylation (OXPHOS), thereby sustaining tumor bioenergetics and redox homeostasis. Pharmacological inhibition or genetic silencing of SLC25A20 impairs tumor growth in vivo. These findings establish SLC25A20 as a key metabolic driver in LUAD and suggest it may be a therapeutic target.<\/jats:p>","DOI":"10.1038\/s41419-026-09119-9","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T18:13:35Z","timestamp":1784830415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SLC25A20 promotes tumor growth by reprogramming energy metabolism in lung adenocarcinoma"],"prefix":"10.1038","volume":"17","author":[{"given":"Xing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxin","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaodi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhua","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1936-2007","authenticated-orcid":false,"given":"Apeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"9119_CR1","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/s1470-2045(23)00444-8","volume":"24","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Vaccarella S, Morgan E, Li M, Etxeberria J, Chokunonga E, et al. Global variations in lung cancer incidence by histological subtype in 2020: a population-based study. Lancet Oncol. 2023;24:1206\u201318. https:\/\/doi.org\/10.1016\/s1470-2045(23)00444-8.","journal-title":"Lancet Oncol"},{"key":"9119_CR2","doi-asserted-by":"publisher","first-page":"975","DOI":"10.21037\/tlcr-24-979","volume":"14","author":"FH Tang","year":"2025","unstructured":"Tang FH, Wong H, Tsang P, Yau M, Tam SY, Law L, et al. Recent advancements in lung cancer research: a narrative review. Transl Lung Cancer Res. 2025;14:975\u201390. https:\/\/doi.org\/10.21037\/tlcr-24-979.","journal-title":"Transl Lung Cancer Res"},{"key":"9119_CR3","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1016\/j.jtho.2021.11.015","volume":"17","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Deng C, Zheng Q, Li Y, Chen H. The grading system of lung adenocarcinoma: ever-evolving concepts. J Thorac Oncol. 2022;17:e30. https:\/\/doi.org\/10.1016\/j.jtho.2021.11.015.","journal-title":"J Thorac Oncol"},{"key":"9119_CR4","doi-asserted-by":"publisher","unstructured":"Paredes R, Borea R, Drago F, Russo A, Nigita G, Rolfo C, et al. Genetic drivers of tumor microenvironment and immunotherapy resistance in non-small cell lung cancer: the role of KEAP1, SMARCA4, and PTEN mutations. J Immunother Cancer. 2025;13. https:\/\/doi.org\/10.1136\/jitc-2025-012288.","DOI":"10.1136\/jitc-2025-012288"},{"key":"9119_CR5","doi-asserted-by":"publisher","first-page":"807497","DOI":"10.3389\/fmolb.2022.807497","volume":"9","author":"P Zheng","year":"2022","unstructured":"Zheng P, Zhang H, Jiang W, Wang L, Liu L, Zhou Y, et al. Establishment of a prognostic model of lung adenocarcinoma based on tumor heterogeneity. Front Mol Biosci. 2022;9:807497. https:\/\/doi.org\/10.3389\/fmolb.2022.807497.","journal-title":"Front Mol Biosci"},{"key":"9119_CR6","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1158\/1078-0432.Ccr-20-5026","volume":"27","author":"SY Kim","year":"2021","unstructured":"Kim SY, Kim SM, Lim S, Lee JY, Choi SJ, Yang SD, et al. Modeling clinical responses to targeted therapies by patient-derived organoids of advanced lung adenocarcinoma. Clin Cancer Res. 2021;27:4397\u2013409. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-20-5026.","journal-title":"Clin Cancer Res"},{"key":"9119_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/science.adj1415","volume":"383","author":"EE Gardner","year":"2024","unstructured":"Gardner EE, Earlie EM, Li K, Thomas J, Hubisz MJ, Stein BD, et al. Lineage-specific intolerance to oncogenic drivers restricts histological transformation. Science. 2024;383:eadj1415. https:\/\/doi.org\/10.1126\/science.adj1415.","journal-title":"Science"},{"key":"9119_CR8","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.7150\/thno.82920","volume":"13","author":"K Yang","year":"2023","unstructured":"Yang K, Wang X, Song C, He Z, Wang R, Xu Y, et al. The role of lipid metabolic reprogramming in tumor microenvironment. Theranostics. 2023;13:1774\u2013808. https:\/\/doi.org\/10.7150\/thno.82920.","journal-title":"Theranostics"},{"key":"9119_CR9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s43018-024-00775-4","volume":"5","author":"KM Tharp","year":"2024","unstructured":"Tharp KM, Kersten K, Maller O, Timblin GA, Stashko C, Canale FP, et al. Tumor-associated macrophages restrict CD8(+) T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment. Nat Cancer. 2024;5:1045\u201362. https:\/\/doi.org\/10.1038\/s43018-024-00775-4.","journal-title":"Nat Cancer"},{"key":"9119_CR10","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.cmet.2022.11.003","volume":"34","author":"Z Gong","year":"2022","unstructured":"Gong Z, Li Q, Shi J, Liu ET, Shultz LD, Ren G. Lipid-laden lung mesenchymal cells foster breast cancer metastasis via metabolic reprogramming of tumor cells and natural killer cells. Cell Metab. 2022;34:1960\u201376.e1969. https:\/\/doi.org\/10.1016\/j.cmet.2022.11.003.","journal-title":"Cell Metab"},{"key":"9119_CR11","doi-asserted-by":"publisher","unstructured":"Chen Y, Zhou Y, Ren R, Chen Y, Lei J, Li Y, et al. Harnessing lipid metabolism modulation for improved immunotherapy outcomes in lung adenocarcinoma. J Immunother Cancer. 2024;12. https:\/\/doi.org\/10.1136\/jitc-2024-008811.","DOI":"10.1136\/jitc-2024-008811"},{"key":"9119_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abk2756","volume":"14","author":"G Wang","year":"2022","unstructured":"Wang G, Qiu M, Xing X, Zhou J, Yao H, Li M, et al. Lung cancer scRNA-seq and lipidomics reveal aberrant lipid metabolism for early-stage diagnosis. Sci Transl Med. 2022;14:eabk2756. https:\/\/doi.org\/10.1126\/scitranslmed.abk2756.","journal-title":"Sci Transl Med"},{"key":"9119_CR13","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41556-018-0124-1","volume":"20","author":"JB Spinelli","year":"2018","unstructured":"Spinelli JB, Haigis MC. The multifaceted contributions of mitochondria to cellular metabolism. Nat Cell Biol. 2018;20:745\u201354. https:\/\/doi.org\/10.1038\/s41556-018-0124-1.","journal-title":"Nat Cell Biol"},{"key":"9119_CR14","doi-asserted-by":"publisher","unstructured":"Napolitano G, Fasciolo G, Venditti P. Mitochondrial management of reactive oxygen species. Antioxidants (Basel). 2021;10. https:\/\/doi.org\/10.3390\/antiox10111824.","DOI":"10.3390\/antiox10111824"},{"key":"9119_CR15","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.1074\/jbc.M109.026203","volume":"285","author":"EL Seifert","year":"2010","unstructured":"Seifert EL, Estey C, Xuan JY, Harper ME. Electron transport chain-dependent and -independent mechanisms of mitochondrial H2O2 emission during long-chain fatty acid oxidation. J Biol Chem. 2010;285:5748\u201358. https:\/\/doi.org\/10.1074\/jbc.M109.026203.","journal-title":"J Biol Chem"},{"key":"9119_CR16","doi-asserted-by":"publisher","unstructured":"Kuznetsov AV, Margreiter R, Ausserlechner MJ, Hagenbuchner J. The complex interplay between mitochondria, ROS and entire cellular metabolism. Antioxidants (Basel). 2022;11. https:\/\/doi.org\/10.3390\/antiox11101995.","DOI":"10.3390\/antiox11101995"},{"key":"9119_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9939331","volume":"2021","author":"Y Wu","year":"2021","unstructured":"Wu Y, Zhang X, Wei X, Feng H, Hu B, Deng Z, et al. A mitochondrial dysfunction and oxidative stress pathway-based prognostic signature for clear cell renal cell carcinoma. Oxid Med Cell Longev. 2021;2021:9939331. https:\/\/doi.org\/10.1155\/2021\/9939331.","journal-title":"Oxid Med Cell Longev"},{"key":"9119_CR18","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.tem.2017.06.004","volume":"28","author":"L Valcarcel-Jimenez","year":"2017","unstructured":"Valcarcel-Jimenez L, Gaude E, Torrano V, Frezza C, Carracedo A. Mitochondrial metabolism: Yin and Yang for tumor progression. Trends Endocrinol Metab. 2017;28:748\u201357. https:\/\/doi.org\/10.1016\/j.tem.2017.06.004.","journal-title":"Trends Endocrinol Metab"},{"key":"9119_CR19","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.celrep.2016.07.009","volume":"16","author":"MS Padanad","year":"2016","unstructured":"Padanad MS, Konstantinidou G, Venkateswaran N, Melegari M, Rindhe S, Mitsche M, et al. Fatty acid oxidation mediated by Acyl-CoA synthetase long chain 3 is required for mutant KRAS lung tumorigenesis. Cell Rep. 2016;16:1614\u201328. https:\/\/doi.org\/10.1016\/j.celrep.2016.07.009.","journal-title":"Cell Rep"},{"key":"9119_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41397-024-00355-w","volume":"24","author":"R Yan","year":"2024","unstructured":"Yan R, Zheng C, Qian S, Li K, Kong X, Liao S. The ZNF263\/CPT1B axis regulates fatty acid \u03b2-oxidation to affect cisplatin resistance in lung adenocarcinoma. Pharmacogenomics J. 2024;24:33. https:\/\/doi.org\/10.1038\/s41397-024-00355-w.","journal-title":"Pharmacogenomics J"},{"key":"9119_CR21","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrc.2016.89","volume":"16","author":"F R\u00f6hrig","year":"2016","unstructured":"R\u00f6hrig F, Schulze A. The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer. 2016;16:732\u201349. https:\/\/doi.org\/10.1038\/nrc.2016.89.","journal-title":"Nat Rev Cancer"},{"key":"9119_CR22","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1021\/jm100809g","volume":"54","author":"SM Ceccarelli","year":"2011","unstructured":"Ceccarelli SM, Chomienne O, Gubler M, Arduini A. Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research. J Med Chem. 2011;54:3109\u201352. https:\/\/doi.org\/10.1021\/jm100809g.","journal-title":"J Med Chem"},{"key":"9119_CR23","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41388-023-02593-x","volume":"42","author":"ZC Nwosu","year":"2023","unstructured":"Nwosu ZC, Song MG, di Magliano MP, Lyssiotis CA, Kim SE. Nutrient transporters: connecting cancer metabolism to therapeutic opportunities. Oncogene. 2023;42:711\u201324. https:\/\/doi.org\/10.1038\/s41388-023-02593-x.","journal-title":"Oncogene"},{"key":"9119_CR24","doi-asserted-by":"publisher","unstructured":"Castelli S, De Falco P, Ciccarone F, Desideri E, Ciriolo MR. Lipid catabolism and ROS in cancer: a bidirectional liaison. Cancers (Basel). 2021;13. https:\/\/doi.org\/10.3390\/cancers13215484.","DOI":"10.3390\/cancers13215484"},{"key":"9119_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1456719","volume":"15","author":"D Fu","year":"2024","unstructured":"Fu D, Zhang B, Fan W, Zeng F, Feng J, Wang X. Fatty acid metabolism prognostic signature predicts tumor immune microenvironment and immunotherapy, and identifies tumorigenic role of MOGAT2 in lung adenocarcinoma. Front Immunol. 2024;15:1456719. https:\/\/doi.org\/10.3389\/fimmu.2024.1456719.","journal-title":"Front Immunol"},{"key":"9119_CR26","doi-asserted-by":"publisher","unstructured":"Tonazzi A, Giangregorio N, Console L, Palmieri F, Indiveri C. The mitochondrial carnitine acyl-carnitine carrier (SLC25A20): molecular mechanisms of transport, role in redox sensing and interaction with drugs. Biomolecules. 2021;11. https:\/\/doi.org\/10.3390\/biom11040521.","DOI":"10.3390\/biom11040521"},{"key":"9119_CR27","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.mam.2012.05.005","volume":"34","author":"F Palmieri","year":"2013","unstructured":"Palmieri F. The mitochondrial transporter family SLC25: identification, properties and physiopathology. Mol Asp Med. 2013;34:465\u201384. https:\/\/doi.org\/10.1016\/j.mam.2012.05.005.","journal-title":"Mol Asp Med"},{"key":"9119_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.149201","volume":"940","author":"Z Gan","year":"2025","unstructured":"Gan Z, Wei X, Zheng Y, Zheng Q, Fan S, Xiong F. Loss-of-function SLC25A20 variant causes carnitine-acylcarnitine translocase deficiency by reducing SLC25A20 protein stability. Gene. 2025;940:149201. https:\/\/doi.org\/10.1016\/j.gene.2024.149201.","journal-title":"Gene"},{"key":"9119_CR29","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1021\/acscentsci.7b00420","volume":"3","author":"CG Parker","year":"2017","unstructured":"Parker CG, Kuttruff CA, Galmozzi A, J\u00f8rgensen L, Yeh CH, Hermanson DJ, et al. Chemical proteomics identifies SLC25A20 as a functional target of the ingenol class of actinic keratosis drugs. ACS Cent Sci. 2017;3:1276\u201385. https:\/\/doi.org\/10.1021\/acscentsci.7b00420.","journal-title":"ACS Cent Sci"},{"key":"9119_CR30","doi-asserted-by":"publisher","unstructured":"Ahmed A, Iaconisi GN, Di Molfetta D, Coppola V, Caponio A, Singh A, et al. The role of mitochondrial solute carriers SLC25 in cancer metabolic reprogramming: current insights and future perspectives. Int J Mol Sci. 2024;26. https:\/\/doi.org\/10.3390\/ijms26010092.","DOI":"10.3390\/ijms26010092"},{"key":"9119_CR31","doi-asserted-by":"publisher","unstructured":"Eltayeb K, La Monica S, Tiseo M, Alfieri R, Fumarola C. Reprogramming of lipid metabolism in lung cancer: an overview with focus on EGFR-mutated non-small cell lung cancer. Cells. 2022;11. https:\/\/doi.org\/10.3390\/cells11030413.","DOI":"10.3390\/cells11030413"},{"key":"9119_CR32","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41420-025-02528-3","volume":"11","author":"G Yu","year":"2025","unstructured":"Yu G, Chen K, Xu B, Cao Q. Mitochondrial SLC25A10 promotes prostate cancer progression by inhibiting ferritinophagy. Cell Death Discov. 2025;11:242. https:\/\/doi.org\/10.1038\/s41420-025-02528-3.","journal-title":"Cell Death Discov"},{"key":"9119_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2024.100625","volume":"5","author":"B Gy\u0151rffy","year":"2024","unstructured":"Gy\u0151rffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innov (Camb). 2024;5:100625. https:\/\/doi.org\/10.1016\/j.xinn.2024.100625.","journal-title":"Innov (Camb)"},{"key":"9119_CR34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrc3483","volume":"13","author":"A Carracedo","year":"2013","unstructured":"Carracedo A, Cantley LC, Pandolfi PP. Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer. 2013;13:227\u201332. https:\/\/doi.org\/10.1038\/nrc3483.","journal-title":"Nat Rev Cancer"},{"key":"9119_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2020","unstructured":"Koundouros N, Poulogiannis G. Reprogramming of fatty acid metabolism in cancer. Br J Cancer. 2020;122:4\u201322. https:\/\/doi.org\/10.1038\/s41416-019-0650-z.","journal-title":"Br J Cancer"},{"key":"9119_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.577420","volume":"10","author":"LP Fern\u00e1ndez","year":"2020","unstructured":"Fern\u00e1ndez LP, G\u00f3mez de Cedr\u00f3n M, Ram\u00edrez de Molina A. Alterations of lipid metabolism in cancer: implications in prognosis and treatment. Front Oncol. 2020;10:577420. https:\/\/doi.org\/10.3389\/fonc.2020.577420.","journal-title":"Front Oncol"},{"key":"9119_CR37","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bbabio.2010.10.022","volume":"1807","author":"LS Pike","year":"2011","unstructured":"Pike LS, Swift AL, Croteau NJ, Ferrick DA, Wu M. Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim Biophys Acta. 2011;1807:726\u201334. https:\/\/doi.org\/10.1016\/j.bbabio.2010.10.022.","journal-title":"Biochim Biophys Acta"},{"key":"9119_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in cancer. Cancer Cell. 2020;38:167\u201397. https:\/\/doi.org\/10.1016\/j.ccell.2020.06.001.","journal-title":"Cancer Cell"},{"key":"9119_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1091\/mbc.E17-01-0041","volume":"29","author":"MR Zanotelli","year":"2018","unstructured":"Zanotelli MR, Goldblatt ZE, Miller JP, Bordeleau F, Li J, VanderBurgh JA, et al. Regulation of ATP utilization during metastatic cell migration by collagen architecture. Mol Biol Cell. 2018;29:1\u20139. https:\/\/doi.org\/10.1091\/mbc.E17-01-0041.","journal-title":"Mol Biol Cell"},{"key":"9119_CR40","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s41418-018-0101-z","volume":"25","author":"HR Fernandez","year":"2018","unstructured":"Fernandez HR, Gadre SM, Tan M, Graham GT, Mosaoa R, Ongkeko MS, et al. The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer. Cell Death Differ. 2018;25:1239\u201358. https:\/\/doi.org\/10.1038\/s41418-018-0101-z.","journal-title":"Cell Death Differ"},{"key":"9119_CR41","doi-asserted-by":"publisher","unstructured":"Mosaoa R, Kasprzyk-Pawelec A, Fernandez HR, Avantaggiati ML. The mitochondrial citrate carrier SLC25A1\/CIC and the fundamental role of citrate in cancer, inflammation and beyond. Biomolecules. 2021;11. https:\/\/doi.org\/10.3390\/biom11020141.","DOI":"10.3390\/biom11020141"},{"key":"9119_CR42","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang S, Li H, Zhang L, Mu W, Zhang Y, Chen T, et al. Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res. 2025;53:D1670\u2013d1676. https:\/\/doi.org\/10.1093\/nar\/gkae973.","journal-title":"Nucleic Acids Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09119-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09119-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09119-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:07:30Z","timestamp":1792454850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09119-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9119"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09119-9","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The investigation has been approved by the Ethics Committee of The Affiliated Cancer Hospital of Nanjing Medical University in Nanjing, China. The serial number is 2023K-Q078.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Written informed consent for publication was obtained from all participants, and the study was approved by the Ethics Committee of The Affiliated Cancer Hospital of Nanjing Medical University in Nanjing, China.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"893"}}